Core Viewpoint - Rosen Law Firm is reminding investors who purchased Oracle Corporation common stock between June 12, 2025, and December 16, 2025, of the April 6, 2026, lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Oracle stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 6, 2026 [2] - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3] Group 2: Case Allegations - The lawsuit alleges that Oracle made false and misleading statements regarding its AI infrastructure strategy, which would lead to significant increases in capital expenditures without corresponding revenue growth [4] - It is claimed that Oracle's increased spending poses risks to its debt, credit rating, free cash flow, and project funding capabilities [4] - The lawsuit asserts that the defendants' representations about Oracle's business and prospects were materially false and misleading, resulting in investor damages when the truth was revealed [4]

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of  securities of Hercules Capital, Inc. (NYSE: HTGC) between May 1, 2025 and February 27, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 19, 2026. SO WHAT: If you purchased Hercules Capital securities during the Class Period you may ...

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Alight, Inc. (NYSE: ALIT) between November 12, 2024 and February 18, 2026, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 15, 2026. SO WHAT: If you purchased Alight common stock during the Class Period you may ...

New York, New York--(Newsfile Corp. - March 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Gartner, Inc. (NYSE: IT) between February 4, 2025 and February 2, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 18, 2026.SO WHAT: If you purchased Gartner common stock during the Class Period ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of monday.com Ltd. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought monday.com common stock between September 17, 2025, and February 6, 2026, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by May 11, 2026 [3]. - The lawsuit alleges that monday.com made false or misleading statements regarding its revenue growth outlook, which included decelerating growth and extended sales cycles, leading to investor damages when the truth was revealed [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms issuing notices may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of significant settlements in securities class actions, including a record settlement against a Chinese company and has recovered hundreds of millions for investors [4]. Group 3: Participation Options - Until a class is certified, investors are not represented by counsel unless they retain one, and they can choose to remain absent from the class [7].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Chanson International Holding due to allegations of materially misleading business information issued to the investing public [1]. Group 1: Investigation Details - The investigation is focused on potential civil securities claims against Chanson International Holding [3]. - Shareholders who purchased Chanson International securities may be entitled to compensation through a contingency fee arrangement, with no out-of-pocket costs [2]. Group 2: Class Action Information - Rosen Law Firm is preparing a class action to seek recovery of investor losses related to Chanson International [2]. - Interested parties can join the prospective class action by submitting a form or contacting the firm directly [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked highly for its number of securities class action settlements and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - A class action lawsuit has been filed against ODDITY Tech Ltd. for misleading statements and undisclosed issues affecting its business and financial prospects during the Class Period from February 26, 2025, to February 24, 2026 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that ODDITY's largest advertising partner made an algorithm change that diverted advertisements to lower quality auctions at higher costs, significantly increasing customer acquisition costs [5]. - Defendants allegedly overstated the strength and sustainability of ODDITY's digital operating model and market position, leading to materially false and misleading public statements [5]. - Investors are entitled to compensation without out-of-pocket fees through a contingency fee arrangement if they purchased ODDITY securities during the Class Period [2]. Group 2: Next Steps for Investors - Investors wishing to join the class action can do so by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by May 11, 2026, to represent other class members in the litigation [1][3]. - Until a class is certified, investors are not represented by counsel unless they retain one, and they can choose to remain absent from the class [7]. Group 3: Rosen Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased REGENXBIO, Inc. securities during the specified class period of the upcoming lead plaintiff deadline on April 14, 2026, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - Investors who bought REGENXBIO securities between February 9, 2022, and January 27, 2026, may be eligible for compensation through a class action lawsuit [1]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2][5]. - The lead plaintiff must file a motion with the court by April 14, 2026, to represent other class members [2]. Group 2: Law Firm Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3]. - The firm has been ranked highly for its number of securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 [3]. - Founding partner Laurence Rosen has received recognition as a leading figure in the plaintiffs' bar, further establishing the firm's credibility [3]. Group 3: Case Background - The lawsuit alleges that REGENXBIO provided misleading information regarding its gene therapy product candidate RGX-111, which is intended for treating severe Mucopolysaccharidosis Type I [4]. - Defendants reportedly made positive assertions about RGX-111's trial success while concealing adverse facts about its efficacy and safety [4]. - The lawsuit claims that when the true information became public, investors suffered damages due to the misleading statements [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Paysafe Limited securities between March 4, 2025, and November 12, 2025, of the April 7, 2026, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Paysafe securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 7, 2026 [2]. - The lawsuit alleges that Paysafe made false or misleading statements and failed to disclose significant risks related to its ecommerce business, which could materially impact its revenue growth and financial guidance for fiscal year 2025 [4]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions for investors [3]. - The firm has been recognized for its leadership in securities class action settlements, achieving notable results including over $438 million secured for investors in 2019 [3]. Group 3: Case Specifics - The lawsuit claims that Paysafe's ecommerce business had significant exposure to a high-risk client, leading to understated credit loss reserves and write-offs [4]. - Issues with higher risk Merchant Category Codes were also not disclosed, complicating client services and likely affecting Paysafe's overall revenue mix [4]. - The misleading statements made by Paysafe's management are said to have caused investor damages when the true details became public [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of SYLA Technologies Co., Ltd. due to allegations of materially misleading business information issued by the company [1][3]. Group 1: Investigation Details - The investigation is focused on potential civil securities claims related to SYLA Technologies [3]. - Shareholders who purchased SYLA Technologies securities may be entitled to compensation through a class action without any out-of-pocket fees [2]. Group 2: Class Action Information - Rosen Law Firm is preparing a class action to seek recovery of investor losses [2]. - Interested investors can join the prospective class action by submitting a form or contacting the firm directly [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in this area [4].